Table 4.
Outcome according to the cardiogenic shock aetiology
Overall cohort | AMI‐CS | ADHF‐CS | P value | |
---|---|---|---|---|
(N = 190) | (N = 101) | (N = 89) | ||
In‐hospital mortality | 78 (41.1) | 39 (38.6) | 39 (43.8) | 0.5 |
Mortality at last available follow‐up a | 85 (44.7) | 44 (43.6) | 41 (46.1) | 0.7 |
LVAD | 11 (6.0) | 2 (2.0) | 9 (11.0) | 0.01 |
Heart transplantation | 12 (6.3) | 0 (0.0) | 12 (13.5) | <0.001 |
Bleeding events during hospital stay b | 28 (14.7) | 13 (13.9) | 14 (15.7) | 0.7 |
BARC minor (<3b) | 9 (33.3) | 4 (30.8) | 5 (35.7) | |
BARC major (≥3b) | 18 (66.7) | 9 (69.2) | 9 (64.3) | |
Follow‐up after discharge, days median (IQR) c | 56 (0–200) | 56 (0–200) | 49 (5–218) | 0.8 |
Re‐hospitalization c | 28 (25.5) | 19 (31.6) | 9 (18.0) | 0.1 |
30 days re‐hospitalization c | 11 (10.0) | 8 (13.3) | 3 (6.0) | 0.2 |
Data are presented as n (%).
ADHF, acute decompensated heart failure; AMI, acute myocardial infarction; BARC, Bleeding Academic Research Consortium; CS, cardiogenic shock; IQR, interquartile range; LVAD, left ventricular assist device.
Median last available follow‐up of 36 days (interquartile range 14–110).
Missing data on details on bleeding type according to BARC for one patient in AMI‐CS group. Percentages are presented on available data.
Among patients survived after index event with available data (110 patients: 60 in AMI‐CS and 50 ADHF‐CS).